Back

Higher prognostic impact of heart failure patients with preserved ejection fraction at younger age: insights from standardized mortality ratios

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Christophe de Terwangne

Cliniques Saint-Luc UCL, Brussels (Belgium)

3 More presentations in this session

Presentation thumbnail
Role of oral semaglutide therapy on incidence of cognitive impairment in a cohort of elderly diabetics with Heart failure with preserved ejection fraction
Professor A. Sciacqua (Catanzaro, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of abnormal right ventricular-pulmonary artery coupling assessed by three-dimensional echocardiography in heart failure with preserved ejection fraction
Professor C. Shim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Red cell distribution width (RDW) and outcomes in HFmrEF/HFpEF: Insights from FINEARTS-HF
Doctor J. Butt (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Personalised approaches to HFpEF: diagnostic tools, biomarkers, and prognostic insights

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Mortality-based clustering reveals distinct subgroups in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Full guideline-directed medical therapy in heart failure patients with reduced ejection fraction: a real-world analysis in older patients with outcome implication
thumbnail
Congress Presentation
Differential effect of sex on mortality according to age in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources